Introduction & Welcome

Adjuvant RT following RP for PCa Systematic review and meta analysis

Eight year outcomes of a phase III randomized trial of conventional versus hypofractionated high dose intensity modulated radiotherapy for prostate cancer

Welcome and Introduction Immunotherapy plus chemotherapy as the New Standard of care for 1L advanced Biliary Tract Cancer(BTC)

New Avenues in the management of advanced Biliary Tract Cancer

Panel Discussion - Metastatic biliary tract cancer First line options It has to be chemothreapy alone

Introduction & Welcome

What Information will help improve our treatment decisions

Relay Data

Welcome & Introduction

Panel Discussion - DIAGNOSTICS IN BREAST CANCER WHERE ARE WE IN 2022

Panel Discussion - Living Longer and Living Well Now a reality in patients with HR+ HER2 aBC

Welcome and Introduction

Recenty Updates in Locally Advanced Prostate Cancer

Panel discussion Role of ADT in the management of prostrate cancer